35
Participants
Start Date
March 27, 2007
Primary Completion Date
January 10, 2008
Study Completion Date
January 10, 2008
GSK561679 tablet
GSK561679 tablets are white film-coated tablets, containing 200 (milligrams) mg of the free base, GSK561679A.
GW876008 tablet
GW876008 tablets are white to off-white round film-coated tablets, containing 100 mg of GW876008X (free base).
alprazolam
Alprazolam capsules 0.25 mg are hard gelatine capsules containing 1 tablet of commercial alprazolam (Xanax 0.25).
Placebo
GW876008 placebo tablets will visually match the active GW876008 tablets. GSK561679 placebo tablets will visually match the active GSK561679 tablets. Placebo to match Alprazolam is a hard gelatine capsule that will visually match the active but containing only a filler.
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Mataro (Barcelona)
GSK Investigational Site, L'Hospitalet de Llobregat
GSK Investigational Site, Sabadell (Barcelona)
GSK Investigational Site, Terrassa - Barcelona
Lead Sponsor
GlaxoSmithKline
INDUSTRY